The world's first Platform-as-a-Service for digital biomarkers.
Most digital biomarkers stay stuck in the lab because moving to clinical use is too expensive and slow. WeGuide Biomarkers is a complete platform that handles the tech, the data, and the regulatory hurdles, so you can turn your research into a tool doctors can actually use.
By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.
.png)
Cost Reduction
Skip the high cost and risk of building from scratch.
Faster validation
Move from a raw idea to a clinical tool in weeks, not years.
TGA ready
Skip the regulatory headache with a platform built for medicalgrade apps.
ISO compliant
Your data is protected by global standards for safety and quality.
so hard to build
Execution
Data collection & running trials is time-consuming and expensive.

%20(1).png)
Integration
Combining fragmented data is technical challenging.
Development
Algorithm creation expertise in data science & trial-and- error.


Distribution
Distribution demands medical certified software and infrastructure.
evidence and commerclise
Design
Set up your study and define the data points (e.g. forms, wearables) and clinical tests that you want to collect.


Engage
Use WeGuide Engage to create the required dataset. Engage with participants and clinicians to collect your multimodal unified dataset.
Develop
Use our AI-powered biomarker development studio to create, score and evaluate algorithms with the click of a button.


Commercialise
Distribute and commercialise your biomarker via our platform so it can be used by pharma, trials or clinical interventions.
research into Biomakers
%20(1).png)
All your data in one place

Find the best biomarker

Ready for clinical use.
.png)
Keep your IP.

Commerialise with ease
Simple tools for a complex world
A digital biomarker is just a way of using technology like a smartwatch or a mobile app to track a person's health in their own home. Instead of a patient coming into a clinic once every six months, you can see how they are actually doing every single day.
It is about moving from a "guess" to "data." Whether it is tracking how someone walks after a stroke or monitoring heart rate during a trial, digital biomarkers give you a clear, continuous picture of a patient’s recovery.
%20(1).png)
How is this different from a custom-built app?
A custom build is a one-off project that is hard to maintain and update. WeGuide is a scalable platform, meaning you get all the benefits of our ongoing security updates and regulatory work without the $3M price tag.
Can I use my own AI models?
Yes. Our studio is a sandbox where you can implement your own logic. We provide the tools to help you refine and validate those models against clinical gold standards.
Is the platform secure?
Security is our priority. We are Australian-owned and operated, and our infrastructure is fully compliant with the Privacy Act and international standards like ISO 27001.
Do you support regional and remote research?
Absolutely. By moving testing from the clinic to the home (BYOD), you can reach participants anywhere in Australia from the middle of Sydney to regional WA.
How does the royalty model work?
When you commercialise a biomarker through our marketplace, WeGuide takes a 30% royalty to cover the ongoing regulatory and hosting costs, while you keep the majority of the revenue.
What biomarkers are already on the platform?
We are currently working on biomarkers for mobility recovery, women's health, and more. Our partnership with NeuRA is the first of many validated tools available for distribution.
By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.





